INCOME TAXES	3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXESOn March 27, 2020, the United States enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) in response to the COVID-19 pandemic. Certain provisions of the legislation had a significant impact on the expected annual effective tax rate, income tax payable, and deferred income tax positions of the Company for the three months ended March 31, 2020. The Company continues to evaluate the provisions of the CARES Act.For the three months ended March 31, 2020, the Company recognized an income tax benefit of $9.6 million compared to income tax expense of $3.2 million for the same period in the prior year. The effective tax rate for this period was 8.2% compared to 17.6% for the same period in the prior year. These effective tax rates differ from the US Federal statutory rate of 21% primarily

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Name:	us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration